The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
Science CNBC Jun 17, 2026
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
